Philip J. Mease, MD, is chief of Rheumatology Clinical Research at Swedish Medical Center, and clinical professor at the University of Washington School of Medicine, both in Seattle.

Dr. Mease is a consultant to, an independent contractor for, and has received research support from Allergan, Boehringer-Ingelheim, Cypress, Eli Lilly, Forest, Jazz, Pfizer, and Wyeth; and is on the advisory board and has received honoraria from Cypress, Forest, Pfizer, and Wyeth. Dr. Mease discusses unapproved/experimental uses of gabapentin, tricyclic antidepressants, and analgesics for the treatment of fibromyalgia.

Roland Staud, MD, is professor of medicine in the Division of Rheumatology and Clinical Immunology, McKnight Brain Institute, at the University of Florida in Gainesville.

Dr. Staud is a consultant to Jazz and has received honoraria from Forest and Jazz.

David A. Williams, PhD, is professor of anesthesiology and medicine (rheumatology), professor of psychiatry and psychology, and associate director of the Chronic Pain and Fatigue Research Center at the University of Michigan in Ann Arbor.

Dr. Williams is a consultant to Eli Lilly, Forest, and Pfizer.